Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Headaches in pregnancy.

Stephen D Silberstein1

  • 1Jefferson Headache Center, 111 South Eleventh Street, Gibbon Building, Suite 8130, Philadelphia, PA 19107, USA. Stephen.Silberstein@jefferson.edu

The Journal of Headache and Pain
|December 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine.

Cephalalgia : an international journal of headache·2025
Same author

Practice advisory for intravenous management of headache disorders in hospitalized patients: a review of the evidence and consensus recommendations.

Regional anesthesia and pain medicine·2025
Same author

Insights from 25 years of onabotulinumtoxinA in migraine - mechanisms and management.

Nature reviews. Neurology·2024
Same author

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials.

Headache·2024
Same author

Clinical factors associated with day-to-day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data.

Headache·2024
Same author

How early can we treat migraine attacks? A perspective based on prodrome.

Med (New York, N.Y.)·2024

Migraine often improves during pregnancy, but can recur postpartum. Limited medication use is advised, prioritizing nonpharmacologic treatments for pregnant women with migraine.

Area of Science:

  • Neurology
  • Obstetrics
  • Pharmacology

Background:

  • Migraine presentation varies during pregnancy, with most women experiencing improvement, while some encounter new or recurring attacks.
  • Medication use in pregnancy is common, yet fetal effects remain incompletely understood.
  • Most drugs are not teratogenic, but adverse outcomes depend on dose, route, and developmental timing.

Discussion:

  • Limited medication use is permissible, not absolutely contraindicated, during pregnancy.
  • Nonpharmacologic therapies are the preferred approach for managing migraine in pregnant individuals.
  • Analgesics like acetaminophen and opioids may be used sparingly when necessary.

Key Insights:

  • Pregnancy-induced migraine changes necessitate careful management strategies.

Related Experiment Videos

  • Risk assessment for medication use must consider fetal developmental stages.
  • Balancing maternal well-being with fetal safety is paramount.

    • Outlook:

    • Further research is needed to fully elucidate the long-term effects of migraine medications on fetal development.
    • Developing safer, evidence-based treatment guidelines for pregnant migraineurs is crucial.
    • Emphasis on nonpharmacologic interventions can minimize medication exposure during gestation.